AT
Abhinav Thakur
About Abhinav Thakur
Data last updated:
Abhinav Thakur is a Director at Curiscent Pharma Private Limited (since 2024) and Director at Speedup Capital Imf Private Limited (since 2025). The largest current company by reported revenue is Curiscent Pharma Private Limited at ₹6.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curiscent Pharma Private Limited U46497MP2024PTC069219 | Director | 02 Jan 2024 | 2024 | ₹6.2 Lakh (FY 2025) | Active |
| Speedup Capital Imf Private Limited U66220MP2025PTC074788 | Director | 14 Feb 2025 | 2025 | Active |
Board colleagues of Abhinav Thakur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sunil Singh | 10348443 | Curiscent Pharma Private Limited | Director |
| Kanahaiya Kumar | 10949222 | Speedup Capital Imf Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhinav Thakur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhinav Thakur
Abhinav Thakur currently holds 2 directorships: Curiscent Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹6.2 Lakh (FY 2025)); Speedup Capital Imf Private Limited (Director, since 14 Feb 2025).
Abhinav Thakur was first appointed on 02 Jan 2024 as Director at Curiscent Pharma Private Limited. The most recent appointment on record is 14 Feb 2025 at Speedup Capital Imf Private Limited.
The current boards of Abhinav Thakur's companies include Sunil Singh (Curiscent Pharma Private Limited), Kanahaiya Kumar (Speedup Capital Imf Private Limited).